| Deep learning enables rapid identification of potent DDR1 kinase inhibitors A Zhavoronkov, YA Ivanenkov, A Aliper, MS Veselov, VA Aladinskiy, ... Nature biotechnology 37 (9), 1038-1040, 2019 | 1035 | 2019 |
| Reinforced Adversarial Neural Computer for de Novo Molecular Design E Putin, A Asadulaev, Y Ivanenkov, V Aladinskiy, B Sanchez-Lengeling, ... Journal of chemical information and modeling 58 (6), 1194-1204, 2018 | 375 | 2018 |
| Entangled conditional adversarial autoencoder for de novo drug discovery D Polykovskiy, A Zhebrak, D Vetrov, Y Ivanenkov, V Aladinskiy, ... Molecular pharmaceutics 15 (10), 4398-4405, 2018 | 251 | 2018 |
| Adversarial Threshold Neural Computer for Molecular de Novo Design E Putin, A Asadulaev, Q Vanhaelen, Y Ivanenkov, AV Aladinskaya, ... Molecular pharmaceutics 15 (10), 4386-4397, 2018 | 223 | 2018 |
| Potential 2019-nCoV 3C-like protease inhibitors designed using generative deep learning approaches A Zhavoronkov, V Aladinskiy, A Zhebrak, B Zagribelnyy, V Terentiev, ... | 211 | 2020 |
| Modeling of human cytochrome P450-mediated drug metabolism using unsupervised machine learning approach D Korolev, KV Balakin, Y Nikolsky, E Kirillov, YA Ivanenkov, NP Savchuk, ... Journal of medicinal chemistry 46 (17), 3631-3643, 2003 | 135 | 2003 |
| Small Molecule Inhibitors of NF- B and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics Y A Ivanenkov, K V Balakin, Y Lavrovsky Mini reviews in medicinal chemistry 11 (1), 55-78, 2011 | 113 | 2011 |
| Recent advances in the synthesis of Fe3O4@ AU core/shell nanoparticles SV Salihov, YA Ivanenkov, SP Krechetov, MS Veselov, NV Sviridenkova, ... Journal of magnetism and magnetic materials 394, 173-178, 2015 | 108 | 2015 |
| Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques S Ekins, KV Balakin, N Savchuk, Y Ivanenkov Journal of medicinal chemistry 49 (17), 5059-5071, 2006 | 108 | 2006 |
| Sorting out antibiotics' mechanisms of action: a double fluorescent protein reporter for high-throughput screening of ribosome and DNA biosynthesis inhibitors IA Osterman, ES Komarova, DI Shiryaev, IA Korniltsev, IM Khven, ... Antimicrobial agents and chemotherapy 60 (12), 7481-7489, 2016 | 100 | 2016 |
| Multicomponent reactions of isocyanides in the synthesis of heterocycles AV Ivachtchenko, YA Ivanenkov, VM Kysil, MY Krasavin, AP Ilyin Russian Chemical Reviews 79 (9), 787, 2010 | 94 | 2010 |
| Shape signatures: new descriptors for predicting cardiotoxicity in silico DS Chekmarev, V Kholodovych, KV Balakin, Y Ivanenkov, S Ekins, ... Chemical research in toxicology 21 (6), 1304-1314, 2008 | 90 | 2008 |
| Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors YA Ivanenkov, SV Vasilevski, EK Beloglazkina, ME Kukushkin, ... Bioorganic & Medicinal Chemistry Letters 25 (2), 404-409, 2015 | 84 | 2015 |
| Comprehensive computational assessment of ADME properties using mapping techniques KV Balakin, YA Ivanenkov, NP Savchuk, AA Ivashchenko, S Ekins Current Drug Discovery Technologies 2 (2), 99-113, 2005 | 83 | 2005 |
| In silico estimation of DMSO solubility of organic compounds for bioscreening KV Balakin, YA Ivanenkov, AV Skorenko, YV Nikolsky, NP Savchuk, ... SLAS Discovery 9 (1), 22-31, 2004 | 77 | 2004 |
| Are we opening the door to a new era of medicinal chemistry or being collapsed to a chemical singularity? Perspective YA Ivanenkov, BA Zagribelnyy, VA Aladinskiy Journal of medicinal chemistry 62 (22), 10026-10043, 2019 | 75 | 2019 |
| Exploring the chemogenomic knowledge space with annotated chemical libraries NP Savchuk, KV Balakin, SE Tkachenko Current opinion in chemical biology 8 (4), 412-417, 2004 | 72 | 2004 |
| Kohonen maps for prediction of binding to human cytochrome P450 3A4 KV Balakin, S Ekins, A Bugrim, YA Ivanenkov, D Korolev, YV Nikolsky, ... Drug Metabolism and Disposition 32 (10), 1183-1189, 2004 | 70 | 2004 |
| New approaches to the treatment of inflammatory disease: focus on small-molecule inhibitors of signal transduction pathways YA Ivanenkov, KV Balakin, SE Tkachenko Drugs in R & D 9, 397-434, 2008 | 69 | 2008 |
| Computational mapping tools for drug discovery YA Ivanenkov, NP Savchuk, S Ekins, KV Balakin Drug Discovery Today 14 (15-16), 767-775, 2009 | 63 | 2009 |
Mark Veselov在 pharmcluster.ru 的电子邮件经过验证
